Printer Friendly
The Free Library
14,610,754 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Incyte Genomics Selects Secant Extreme Enterprise Server; Secant Technologies provides key elements of Incyte's Genomic Knowledge Platform for Life Science Research.


Business/Technology Editors

CLEVELAND--(BUSINESS WIRE)--Sept. 11, 2000

Secant Technologies, Inc. today announced that, after an extensive technology evaluation, Incyte Genomics, Inc. (Nasdaq: INCY), the leading genomic genomic

pertaining to a genome.


genomic clone
see clone.

genomic DNA
the DNA sequences making up the genome of an individual.

genomic library
see gene bank.
 information company, has selected Secant's Extreme(TM) Enterprise Server as a major element of its new Genomic Knowledge Platform, a unified software environment for bioinformatics research. Secant's award-winning infrastructure software was selected as the foundation to rapidly develop, deploy and deliver Incyte's unique human gene information to academic, biotechnology and pharmaceutical researchers around the world.

Secant's application server technology is well suited for life sciences. Secant has tightly integrated its code generation technology with object modeling tools to dramatically reduce the time-to-market of large scale, database intensive applications. In addition, intelligent clustering, transaction, and data management services provide the vast scalability, performance, and fault tolerance See fault tolerant.

(architecture) fault tolerance - 1. The ability of a system or component to continue normal operation despite the presence of hardware or software faults. This often involves some degree of redundancy.

2.
 required by systems like the Genomic Knowledge Platform.

Incyte and Secant are combining advances in science with advances in enterprise computing Refers to information technology in the larger company. See enterprise data and enterprise networking.  to revolutionize rev·o·lu·tion·ize  
tr.v. rev·o·lu·tion·ized, rev·o·lu·tion·iz·ing, rev·o·lu·tion·iz·es
1. To bring about a radical change in: Television has revolutionized news coverage.

2.
 the way in which scientists conduct research and share information. "Secant's technologies have been key to the success of our new Genomic Knowledge Platform enabling us to efficiently map complex biological models to our multiple genomic information sets," said Roy Whitfield, Incyte's chief executive officer.

"To provide tools powerful enough to study the breadth of human gene information, we needed an infrastructure to support a complex object model, vast scalability and extensive object-to-relational data management. When we evaluated the leading application servers, we found that Secant's technologies were more advanced than everything else we considered," said Lee Grover, vice president of software development of Incyte Genomics. "With Secant's technology, we feel confident our applications can be deployed and managed on the broad scale we require."

Secant has received numerous industry awards including Network Computing's 2000 Well-Connected Award for Best Java Application A Java program that is run stand alone. The Java Virtual Machine in the client or server is interpreting the instructions. Contrast with Java applet. See servlet.  Server, Oracle's 1999 Top 50 List of e-Business Solution Providers, and a 1999 Editor's Choice Award from Java Developer's Journal. "Our technology has been generating a lot of excitement in the marketplace by winning a string of industry awards," states Jim Holt Jim L. Holt, born January 17, 1965 in Camden, Arkansas is a conservative Republican politician from Springdale, Arkansas. Background
Holt joined the military in 1987 and served in the U.S.
, president of Secant. "But, we consider having customers like Incyte that base their key enterprise initiatives on our technology as our most significant award."

About Incyte

Incyte Pharmaceuticals, Inc. (doing business as Incyte Genomics, Inc.) is the leading provider of an integrated platform of genomic technologies designed to aid in the understanding of the molecular basis of disease. Incyte develops and markets genomic databases and partnership programs, genomic data management software, microarray-based gene expression services, related reagents and services. These products, programs and services assist pharmaceutical and biotechnology researchers with all phases of drug discovery and development including gene discovery, understanding disease pathways, identifying new disease targets and the discovery and correlation of gene sequence variation to disease. For more information, visit Incyte's web site at www.incyte.com.

About Secant Technologies

Secant Technologies, Inc. is a leading provider of high-performance application server technology for building, deploying, hosting and managing the most demanding e-Business applications. With an emphasis on object-oriented and Internet technologies, Secant provides a complete platform for enterprise-caliber technology based on open standards Specifications for hardware and software that are developed by a standards organization or a consortium involved in supporting a standard. Available to the public for developing compliant products, open standards imply "open systems;" that an existing component in a system can be replaced . Organizations that have recognized business benefits from the use of Secant's products include Incyte Genomics, XOL XOL Ontology Exchange Language
XOL Excess of Loss (insurance)
XOL Diskless X Office Linux
XOL Extension of Life
XOL Xinhuaonline
XOL XML Based Ontology Language
XOL Object Language Editor (file extension) 
.com, Lockheed-Martin, Siemens, Deutsche Bank Deutsche Bank AG (IPA: /'dɔɪ.tʃə/[1]) (ISIN: DE0005140008, NYSE: DB) (English: German Bank , i2 Technologies, Detroit Edison Detroit Edison, founded in 1903, is an investor-owned electric utility which serves most of Southeast Michigan. Its parent company, DTE Energy (NYSE: DTE), provides energy services to a variety of clients beyond Detroit Edison's service area. , Triton Container, and Susquehanna Partners. Founded in 1995, Secant Technologies is headquartered in Cleveland, Ohio "Cleveland" redirects here. For the Cleveland metropolitan area, see . For other uses, see Cleveland (disambiguation).
Cleveland is a city in the U.S. state of Ohio and the county seat of Cuyahoga County, the most populous county in the state.
. More information is available at http://www.secant.com.

Secant Extreme and Extreme Enterprise Server are trademarks of Secant Technologies, Inc. All other products are trademarks of their respective rightsholders.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 11, 2000
Words:584
Previous Article:IBM Innovation To Improve 'Internet Experience'.
Next Article:FONAR To Sell Viatronix's Virtual Colonoscopy Equipment; Company Eyes Non-Invasive Colon Screening on MRIs.
Topics:



Related Articles
Incyte Signs IBM as Key Technology Partner to Offer Solutions for Life Sciences.
ONLINE PROGRAM ACCELERATES MEDICAL RESEARCH PROGRAMS.(Product Announcement)
TogetherSoft and Secant Integrate Their Products to Extend E-solution Building Blocks to Large-scale Enterprise Applications.
Secant Technologies Demonstrates Computing Farm Software for IBM Linux Solutions; Software Infrastructure Scales to Meet the Advanced Demands of Life...
Secant Technologies Founder Named an Ernst & Young Entrepreneur of the Year.
Acero Partners With Oracle to Provide Science-Intelligent Enterprise Solutions for Life Sciences.
INCYTE GENOMICS SIGNS AGREEMENT WITH ACCELRYS.
The challenges of data management in biotech: booming life sciences research has IT resources bursting at the seams. (Storage Networking).(Industry...
LION GETS NEW AND UPGRADED LICENSES FOR SRS.
Identification of platform-independent gene expression markers of cisplatin nephrotoxicity.(Genomics and Risk Assessment: Mini-Monograph)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles